Related Experiment Video
Updated: Sep 22, 2025

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
PINK1/Parkin-mediated mitophagy in cardiovascular disease: From pathogenesis to novel therapy
Yanze Wu1, Ting Jiang2, Jinghai Hua3
1Department of Cardiology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China; Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, China.
Insights
Cardiovascular disease involves mitochondrial dysfunction. PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy clears damaged mitochondria, crucial for heart health and treating cardiovascular diseases.
Area of Science:
- Cardiology
- Mitochondrial Biology
- Cellular Metabolism
Background:
- Cardiovascular disease (CVD) is a leading cause of death and morbidity.
- Mitochondria are vital for cardiac energy metabolism, but dysfunction causes oxidative damage.
- Impaired mitochondria clearance, via mitophagy, is essential for cardiac homeostasis.
Purpose of the Study:
- To discuss the roles of PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy in the cardiovascular system.
- To explore the physiological and pathological significance of PINK1/Parkin-mediated mitophagy in cardiovascular diseases.
- To highlight potential therapeutic strategies targeting PINK1/Parkin-mediated mitophagy for CVD prevention and treatment.
Main Methods:
- Literature review of studies on PINK1/Parkin-mediated mitophagy in cardiovascular contexts.
- Analysis of the physiological and pathological roles of this specific mitophagy pathway.
- Exploration of therapeutic interventions modulating PINK1/Parkin-mediated mitophagy.
Main Results:
- PINK1/Parkin-mediated mitophagy is crucial for maintaining cardiomyocyte homeostasis.
- Dysfunctional mitochondria and excessive ROS production contribute to cardiovascular pathology.
- Modulation of PINK1/Parkin-mediated mitophagy shows therapeutic potential for CVD.
Conclusions:
- PINK1/Parkin-mediated mitophagy plays a significant role in cardiovascular health and disease.
- Targeting this pathway offers promising therapeutic avenues for cardiovascular diseases.
- Further research into PINK1/Parkin-mediated mitophagy is vital for CVD prevention and treatment.
Abstract:
Cardiovascular disease(CVD)is one of the predominant causes of death and morbidity. Mitochondria play a key role in maintaining cardiac energy metabolism. However, mitochondrial dysfunction leads to excessive production of ROS, resulting in oxidative damage to cardiomyocytes and contributing to a variety of cardiovascular diseases. In such a case, the clearance of impaired mitochondria is necessary. Currently, most studies have indicated an essential role for mitophagy in maintaining cardiac homeostasis and regulating CVD-related metabolic transition. Recent studies have implicated that PTEN-induced putative kinase 1 (PINK1)/Parkin-mediated mitophagy has been implicated in maintaining cardiomyocyte homeostasis. Here, we discuss the physiological and pathological roles of PINK1/Parkin-mediated mitophagy in the cardiovascular system, as well as potential therapeutic strategies based on PINK1/Parkin-mediated mitophagy modulation, which are of great significance for the prevention and treatment of cardiovascular diseases.
More Related Videos
09:29Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
06:57Author Spotlight: Fluorescence-Based Quantification of Mitochondrial Membrane Potential and Superoxide Levels Using Live Imaging in HeLa Cells
Published on: May 12, 2023
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...